Recombinant cytomegaloviruses for study of replication and pathogenesis

Intervirology

Volumn 39, Issue 5-6, 1996, Pages 320-330

  Mocarski, Edward S ^a   Kemble, George W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetics; Herpesvirus; Human; Mouse; Mutagenesis

Indexed keywords

CIS ACTING ELEMENT;

ANIMAL MODEL; ARTICLE; COSMID; CYTOMEGALOVIRUS; GENETIC MARKER; HUMAN CYTOMEGALOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS LATENCY; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; COSMIDS; CYTOMEGALOVIRUS; GENES, VIRAL; GENETIC MARKERS; HUMANS; MICE; MUROMEGALOVIRUS; MUTATION; RECOMBINATION, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; VIRUS REPLICATION;

ANIMALIA; CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 12644282521     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150503     Document Type: Article

References (124)

1. Spacte RR, Mocarski ES: Insertion and deletion mutagenesis of the human cytomegalovirus genome, Proc Natl Acad Sei USA 1987:84: 7213-7217.
2. Manning WC, Mocarski ES: Insertional mutagenesis of the murine cytomegalovirus genome: One prominent alpha gene (ie2) is dispensable for growth, Virology 1988:167:477-484.
3. Manning WC, Stoddart CA, Lagenaur LA, Abcnes GB, Mocarski ES: Cytomegalovirus determinant of replication in salivary glands, J Virol 1992:66:3794-3802.
4. Jones TR, Muzithras VP, Gluzman Y: Replacement mutagenesis of the human cytomegalovirus genome: US10 and USU gene products are nonessential, J Virol 1991:65:5860-5872.
5. Jones TR, Muzithras VP: A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS I, US I through US5, and the US6 family, J Virol 1992:66: 2541-2546.
6. Ripalli A, Mocarski ES: The products of human cytomegalovirus genes ULI-UL7, including gp48, arc dispensable for growth in cell culture: in Landini MP (ed): Progress in Cytomegalovirus Research: Proceedings of the Third International Cytomegalovirus Workshop, Amsterdam, Elsevier, 1991, pp 57-62.
7. Kaye J, Brown H, Stoffel M, Minson T: The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro, J Virol 1992;66:6606-6615.
8. Browne H, Churcher M, Minson T: Construction and characterization of a human cytomegalovirus mutant with the ULI8 (class I homo-logue) gene deleted, J Virol 1992:66:6784-6787.
9. Kemble GW, Mocarski ES: A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence, J Virol 1989:63:4715-4728.
10. Kohler CP, Kerry JA, Carter M, Muzithras VP, Jones TR, Stcnbcrg RM: Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome, J Virol 1994:68:6589-6597.
11. Prichard MN, Mocarski ES: Mutation of modulator region upstream of the human cytomegalovirus iel/iel promotcr-enhancer delays gene expression and viral replication, J Gen Virol, submitted.
12. Ho DY, Mocarski ES: p-Galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse, Virology 1988:167:279-283.
13. Ho DY, Mocarski ES: Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse, Proc Natl Acad Sci USA 1989;86:7596-7600.
14. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abcnes GB, Mocarski ES: Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus, J Virol 1994:68:6243-6253.
15. Mocarski ES, Bonyhadi M, Salirni S, McCune JM, Kaneshima H: Human cytomegalovirus in a SCID-hu mouse: Thymic epithelial cells are prominent targets of viral replication, Proc Natl Acad Sei USA 1993:90:104-108.
16. Chee MS, Bankier AT, Beck S, Bohni R, Brown CM, Cemy R, Horsncll T, Hutchison CAI, Kouzaridcs T, Martignetti JA, Prcddie E, Stachwell SC, Tomlinson P, Weston KM, Barren BG: Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD 169, Curr Top Microbiol Immunol 1990;154:125-170.
17. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR: Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains, J Virol 1996:70: 78-83.
18. Brown JM, Kaneshima H, Mocarski ES: Dramatic interstrain differences in the replication ofhuman cytomegalovirus in SC'lD-hu mice, J Infect Dis 1995;171:1599-1603.
19. Mocarski ES: Cytomegalovirus biology and replication: in Roizman B, Whitley R, Lopez C (eds): The Human Herpesviruses, New York, Raven Press, 1993, pp 173-226.
20. Rawlinson WD, Farrell HE, Barrell BG: Analysis of the complete DNA sequence of murine cytomegalovirus (MCMV), J Virol 1996:70: 8833-8849.
21. Takckoshi M, Macda-Takekoshi F, Ihara S, Sakuma S, Watanabc Y: Site-specific stable insertion into the human cytomegalovirus genome of a foreign gene under control of the SV40 promoter, Gene 1991:101:209-213.
22. Kollcrt-Jons A, Bogner E, Radsak K: A 15-kilo-basc-pair region of the human cytomegalovirus genome which includes USI through US13 is dispensable for growth in cell culture, J Virol 1991;65:5184-5199.
23. Wolff D, Jahn G, Plachter B: Generation and effective enrichment of selectable human cytomegalovirus mutants using site-directed insertion of the ncogene, Gene 1993:130:167-173.
24. Schmolkc S, Kern HF, Drescher P, Jahn G, Plachter B: The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for grow'th in cell culture, J Virol 1995;69:5959-5968.
25. Prichard MN, Duke GM, Mocarski ES: Human cytomegalovirus uracil DNA glycosidase is required for normal temporal regulation of both DNA synthesis and viral replication, J Virol 1996;70:3018-3025.
26. Greaves RF, Brown JM, Vieira J, Mocarski ES: Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene, J Gen Virol 1995:76: 2151-2160.
27. Duke G, Mocarski ES: The most abundant human cytomegalovirus transcript, the ßj,? RNA, is noncsscntial for viral replication in primary human fibroblasts, J Virol, submitted.
28. Smith MG: Propagation of salivary gland virus of the mouse in tissue cultures, Proc Soc Exp Biol Med 1954:86:435-440.
29. Compels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin ME, Efstathiou S, Craxton M, Macaulay HA: The DNA sequence ofhuman herpesvirus-6: Structure, coding content, and genome evolution, Virology 1995: 209:29-51.
30. Mocarski ES: Cytomegaloviruses and their replication; in Fields BN, Knipc DM, Howley PM (eds): Fields Virology, New York, Lippin-cott-Raven Publishers, 1995, pp 2447-2492.
31. Masse MJ, Karlin S, Schachtel GA, Mocarski ES: Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region, Proc Natl Acad Sci USA 1992:89:5246-5250.
32. Masse MJ, Messerle M, Mocarski ES: The location and sequence composition of the murine cytomegalovirus replicator (oriLyt), Virology, submitted.
33. Stinski MF, Thomsen DR, Slenberg RM, Goldstein LC: Organization and expression of the immediate early genes ofhuman cytomegalovirus, J Virol 1983:46:1-14.
34. Keil GM, Ebeling KA, Koszinowski UH: Immediate-early genes of murine cytomegalovirus: Location, transcripts, and translation products, J Virol 1987:61:526-533.
35. Mocarski ES: Cytomegalovirus: in Webster R, Granoff A (eds): Encyclopedia of Virology, London, Saunders, 1993.
36. Boname JM, Chantler JK: Characterization of a strain of murine cytomegalovirus which fails to grow in the salivary glands of mice, J Gen Virol 1992:73:2021 -2029.
37. Boname JM, Lagenaur LA, Mocarski ES: Murine cytomegalovirus genes influencing virus growth and tropism for salivary glands; in Becker Y, Darai G (eds): Pathogenicity of human herpesviruses due to specific pathogenicity genes, Berlin, Springer, 1994, vol 3, pp 315-328.
38. Vieira J, Farrell HE, Rawlinson WD, Mocarski ES: Genes in the IlindlU J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: Insertion mutagenesis with a lacZlgpl cassette, J Virol 1994: 68:4837-4846.
39. Thalc R, Szepan U, Hengel H, Gcginat G, Lucin P, Koszinowski UH: Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport, J Virol 1995:69:6098- 6105.
40. Thale R, Lucin P, Schneider K, Eggcrs M, Koszinowski UH: Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor, J Virol 1994,68:7757-7765.
41. Cavanaugh VJ, Slenberg RM, Staley TL, Virgin HW, MacDonald MR, Paetzold S, Farrell HE, Rawlinson WD, Campbell AE: Murine cytomegalovirus with a deletion of genes spanning mdlll-J and -I displays altered cell and tissue tropism, J Virol 1996:70:1365-1374.
42. Lagenaur LA, Manning WC, Vieira J, Martens CL, Mocarski ES: Structure and function of the murine cytomegalovirus.vgijl gene: A determinant of viral growth in salivary gland acinar cells, J Virol 1994:68:7717-7727.
43. del Val M, Hengel H, Hacker H, Hartlaub U, Ruppcrt T, Luein P, Koszinowski UH: Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment, J Exp Med 1992;176:729-738.
44. Jones TR, Hanson LK, Sun L, Slater JS, Sten-berg RM, Campbell AE: Multiple independent loci within the human cytomegalovirus unique short region down-rcgulate expression of major histocompatibility complex class I heavy chains, J Virol 1995;69:4830-4841.
45. Cardin RD, Abenes GB, Stoddart CA, Mocarski ES: Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice, Virology 1995:209: 236-241.
46. Cardin RD, Boname JM, Abenes GB, Jennings SA, Mocarski ES: Reactivation of murine cytomegalovirus from latency, in Plolkin S, Michcl-son S (eds): Multidisciplinary Approaches to Understanding Cytomegalovirus Disease, Amsterdam, Elsevier, 1993, pp 101-110.
47. Messerle M, Kcil GM, Koszinowski UH: Structure and expression of murine cytomegalovirus immcdiate-carlv gene 2, J Virol 1991:65:1638-1643.
48. Kemble G, Duke G, Winter R, Spaete R: Defined large scale alteration of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids, J Virol 1996; 70:2044-2048.
49. aa is replication defective due to a failure in autoregulation, Proc Natl Acad Sci USA 1996:93:11321- 11326.
50. Takckoshi M, Macda-Takekoshi E, Iltara S, Sakuma S, Watanabe Y: Inducible expression of a foreign gene inserted into the human cytomegalovirus genome, J Gen Virol 1993;74: 1649-1652.
51. Manning WC: Murine cytomegalovirus genes involved in viral pathogenesis and latency, Stanford, Stanford University, 1990.
52. Mulligan RC, Berg P: Selection for animal cells that express the Escherichia coli gene coding for xanthinc-guaninc phosphoribosyltransferasc, Proc Natl Acad Sci USA 1981;78:2072-2076.
53. Mocarski ES, Post LE, Roizman B: Molecular engineering of the herpes simplex virus genome: Insertion of a second L-S junction into the genome causes additional genome inversions, Cell 1980:22:243-255.
54. Post LE, Roizman B: A generalized technique for deletion of specific genes in large genomes: Alpha gene 22 of herpes simplex virus 1 is not essential for growth, Cell 1981:25:227-232.
55. van Zijl M, Quint W, Briairc J, de Rover T, Gielkens A, BernsA: Regeneration of herpesviruses from molccularly cloned subgenomic fragments, J Virol 1988:62:2191-2195.
56. Cohen JI, Seidel KE: Generation of varicella-zoster virus (VZV) and viral mutants from cos-mid DNAs: VZV thymidylate synthetase is not essential for replication in vitro, Proc Natl Acad Sci USA 1993:90:7376-7380.
57. Tomkinson B, Robertson E, Yalamanchili R, Longneckcr R, Kieff E: Epstein-Barr virus recombinants from overlapping cosmid fragments, J Virol 1993:67:7298-7306.
58. Cunningham C, Davison AJ: A cosmid-based system for constructing mutants of herpes simplex virus type I, Virology 1993; 197:116-124.
59. Mocarski ES, Liu AC, Spaete RR: Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain), J Gen Virol 1987;68:2223-2230.
60. Dutko FJ, Oldstone MB: Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell differentiation, J Exp Med 1981:154:1636-1651.
61. Gonczol E, Andrews PW, Plotkin SA: Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells, Science 1984:224:159-161.
62. Muller MT, Hudson JB: Cell cycle dependency of murine cytomegalovirus replication in synchronized 3T3 cells, J Virol 1977:22:267-272.
63. Compton T: An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection, J Virol 1993:67:3644-3648.
64. Nevins JR: Disruption of ccll-cyclc control by viral oncoproteins, Biochem Soc Trans 1993; 21:935-938.
65. Halbert CL, Demers GW, Galloway DA: The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells, J Virol 1991:65:473-478.
66. Reisntan D, Yates J, Sugden B: A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two czs-act-ing components, Mol Cell Biol 1985:5:1822- 1832.
67. Duclos H, Elfassi E, Michclson S, Arcnzana Seisdcdos F, Hazan U, Munier A, Virclizier JL: Cytomegalovirus infection and trans-activation of HIV-1 and HIV-2 LTRs in human astrocytoma cells, AIDS Res Hum Retroviruses 1989:5:217-224.
68. Poland SD, Costello P, Dekaban GA, Rice GP: Cytomegalovirus in the brain: In vitro infection of human brain-derived cells, J Infect Dis 1990;162:1252-1262.
69. Jault FM, Spcctor SA, Spector DH: The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus, J Virol 1994;68:959-973.
70. Reis B, Bogner E, Reschkc M, Richter A, Mockenhaupt T, Radsak K: Stable constitutive expression of glycoprotein B (gpUL55) of human cytomegalovirus in permissive astrocytoma cells, J Gen Virol 1993:74:1371-1379.
71. Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pcrieira L: Function of human cytomegalovirus glycoprotein B: Syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies, Virologv 1994; 201:263-276.
72. Riplati A, Boccuni MC, Campanini F, Landini MP: Cytomegalovirus-mediated induction of anliscnse ntRNA expression to U1.44 inhibits virus replication in an astrocytoma cell line: Identification of an essential gene, J Virol 1995:69:2047-2057.
73. Klucher KM, Sommer M, Kadonaga JT, Spector DH: In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins, Mol Cell Biol 1993:13:1238-1250.
74. Staczck J: Animal cytomegaloviruses, Microbiol Rev 1990;54:247-265.
75. DiLorcto D Jr, Epstein LG, Lazar F.S, Britt WJ, del Cerro M: Cytomegalovirus infection of human retinal tissue: An in vivo model, Lab Invest 1994:71:141-148.
76. Kondo K, Kaneshima H, Mocarski ES: Human cytomegalovirus latent infection of granulo-cytc-macrophagc progenitors, Proc Natl Acad Sci USA 1994;91:11879-11883.
77. Kondo K, Xu J, Mocarski ES: Human cytomegalovirus latency-specific gene expression in granulocytc-macrophage progenitors in culture and in healthy seropositive individuals, Proc Natl Acad Sci USA 1996;93:11137-11142.
78. Minton EJ, Tysoc C, Sinclair JH, Sissons JG: Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow, J Virol 1994;68:4017-4021.
79. von Laer D, Meyer-Koenig U, Serr A, Finkc J, Kanz L, Fauscr AA, Ncumann-Haefclin D, Brugger W, Hufert FT; Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow, Blood 1995:86:4086-4090.
80. Bcvan IS, Daw RA, Day PJ, Ala FA, Walker MR: Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population, Br J Haematol 1991:78:94-99.
81. Taylor-Wiedcman J, Sissons JG, Borysiewiez LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells, J Gen Virol 1991;72:2059-2064.
82. Stanier P, Kitchen AD, Taylor DL, Tynis AS: Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR, Mol Cell Probes 1992;6:51-58.
83. Mims CA, Gould J: Infection of salivary glands, kidneys, adrenals, ovaries and epithclia by murine cytomegalovirus, J Med Microbiol 1979;12:113-122.
84. Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shcllam GR: Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen, J Exp Med 1990:171:1469-1483.
85. Koszinowksi UH, del Val M, Reddehasc MJ: Cellular and molecular basis of the protective immune response to cytomegalovirus infection, Curr Top Microbiol Immunol 1990:154: 189-220.
86. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH: Site-restricted persistent cytomegalovirus infection after selective longterm depletion of CD4+ T lymphocytes, J Exp Med 1989:169:1199-1212.
87. Lucin P, Pavic I, Polic B, Jonjic S, Koszi-nowski UH: Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands, J Virol 1992:66:1977-1984.
88. Osbom JH, Walker DL: Virulence and attenuation of murine cytomegalovirus, Infect lm-mun 1971:3:228-236.
89. Chong K.T, Mims CA: Murine cytomegalovirus particle types in relation to sources of virus and pathogenicity, J Gen Virol 1981:57: 415-419.
90. Mims CA, Gould J: The role of macrophages in mice infected with murine cytomegalovirus, J Gen Virol 1978;41:143-153.
91. Brautigam AR, Dutko FJ, Olding LB, Old-stone MB: Pathogenesis of murine cytomegalovirus infection: The macrophage as a permissive cell for cytomegalovirus infection, replication and latency, J Gen Virol 1979:44: 349-359.
92. Jordan MC, Mar VL: Spontaneous activation of latent cytomegalovirus from murine spleen cxplants, Role of lymphocytes and macrophages in release and replication of virus, J Clin Invest 1982:70:762-768.
93. Jordan MC, Takagi JL, Stevens JG: Activation of latent murine cytomegalovirus in vivo and in vitro: A pathogenic role for acute infection, J Infect Dis 1982:145:699-705.
94. Ho M: Cytomegalovirus: Biology and Infection, ed 2, New York, Plenum Publishing, 1991.
95. Reddchase MJ, Balthcsen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH: The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease, J Exp Med 1994;179:185-193.
96. Jonjic S, Pavic I, Polic B, Cmkovic I, Lucin P, Koszinowski UH: Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent vims, J Exp Med 1994:179:1713-1717.
97. Jordan MC: Latent infection and the elusive cytomegalovirus, Rev Infect Dis 1983,5:205-215.
98. Perot K, Walker CM, Spaetc RR: Primary chimpanzee skin fibroblast cells are fully permissive for human cytomegalovirus replication, J Gen Virol 1992:73:3281-3284.
99. Clark BR, Zaia JA, Balcc DL, Ting YP: Isolation and partial chemical characterization of a 64,000-dalton glycoprotein of human cytomegalovirus, J Virol 1984:49:279-282.
100. Nowak B, Gmeiner A, Samow P, Levine AJ, Fleckenstein B: Physical mapping of human cytomegalovirus genes: Identification of DNA sequences coding for a virion phospho-protein of 71 kDa and a viral 65-kDa polypeptide, Virology 1984; 134:91 - 102.
101. Greenaway PJ, Wilkinson GW: Nucleotide sequence of the most abundantly transcribed early gene of human cytomegalovirus strain AD 169, Vims Res 1987:7:17-31.
102. Fish KN, Depto AS, Moses AV, Britt W, Nelson JA: Growth kinetics of human cytomegalovirus arc altered in monocyte-derived macrophages, J Virol 1995:69:3737-3743.
103. Waldman WJ, Knight DA, Huang EH, Sed-mak DD: Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: An in vitro model, J Infect Dis 1995:171:263-272.
104. Waldman WJ, Roberts WH, Davis DH, Williams MV, Scdmak DD, Stephens RE: Preservation of natural endothelial cylopathogcn city of cytomegalovirus by propagation in endothelial cells, Arch Virol 1991:117:143-164.
105. Beck S, Barrcll BG: Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens, Nature 1988:331:269-272.
106. Browne H, Smith G, Beck S, Minson T: A complex between the MHC class I homologue encoded by human cytomegalovirus and bcta-2-microglobulin, Nature 1990:347:770- 772.
107. Beck S, Barrcll B: An HCMV reading frame which has similarity with both the V and C regions of the TCR gamma chain, DNA Scq 1991:2:33-38.
108. Ncote K, DiGregorio D, Mak JY, Homk R, Schall TJ: Molecular cloning, functional expression, and signaling characteristics ofaC-C chemokine receptor, Cell 1993:72:415- 425.
109. Pereira L, Maidji E, Tugizov S, Jones T: Deletion mutants in human cytomegalovirus glycoprotein US9 are impaired in cell-cell transmission and in altering tight junctions of polarized human retinal pigment epithelial cells, Scand J Infect Dis 1995:99(suppl):82-87.
110. Smith MA, Brcnnesscl DJ: Cytomegalovirus, Infect Dis Clin North Am 1994:8:427-438.
111. Colberg-Polev AM, Santomenna LD, Harlow PP, Benfield PA, Tenney DJ: Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression, J Virol 1992:66:95-105.
112. Tenney DJ, Santomenna LD, Goudie KB, C'olberg-Poley AM: The human cytomegalovirus US3 immediate-early protein lacking the putative transmembrane domain regulates gene expression, Nucleic Acids Res 1993;21:2931-2937.
113. Mullaney J, Moss HW, McGcoch DJ: Gene UL2 of herpes simplex virus type I encodes a urail-DNA glvcosidasc, J Gen Virol 1989:70: 449-454.
114. Pari GS, Anders DG: Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus or/Lyt-dcpendent DNA replication, J Virol 1993;67:6979-6988.
115. Stenbcrg RM: Immediate-early genes of human cytomegalovirus: Organization and function; in Huang ES (ed): Molecular Aspects of Human Cytomegalovirus Diseases, Heidelberg, Springer, 1993, pp 330-359.
116. Roy N: Generation of influenza-specific cytotoxic T-lymphocytcs by retroviral gene transfer, New York, Cornell University School of Medicine, 1993.
117. Cherrington JM, Mocarski ES: Human cytomegalovirus /VI transactivates tha a promot-er-cnhancer via an 18-base-pair repeat clement, J Virol 1989:63:1435-1440.
118. Sambucetti LC, Cherrington JM, Wilkinson GWG, Mocarski ES: N'F-kB activation of the cytomegalovirus enhancer is mediated by a viral transaclivator and by T cell stimulation, EMBOJ 1989:8:4251-4258.
119. Spacte RR, Mocarski ES: Regulation of cytomegalovirus gene expression: a and J promoters are trans-activated by viral functions in permissive human fibroblasts, J Virol 1985: 56:135-143.
120. Stinski MF, Roehr TJ: Activation of the major immediate early gene of human cytomegalovirus by m-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components, J Virol 1985:55: 431-441.
121. Liu B, Stinski MF: Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATE and AP-1 m-acting elements, J Virol 1992;66:4434-4444.
122. Klucher KM, Rabert DK, Spector DH: Sequences in the human cytomegalovirus 2.7-kilobasc RNA promoter which mediate its regulation as an early gene, J Virol 1989:63: 5334-5343.
123. Silver S, Roizman B: gamma 2-Thymidine kir.ase chimeras arc identically transcribed but regulated as gamma 2 genes in herpes simplex virus genomes and as beta genes in cell genomes, Mol Cell Biol 1985:5:518-528.
124. Mocarski ES, Abcnes GB, Manning WC, Sambucetti LC, Cherrington JM: Molecular genetic analysis of cytomegalovirus gene regulation in growth, persistence and latency, Curr Top Microbiol Immunol 1990:154:47- 74.